Epiprobe ibikoresho bitatu byo gupima kanseri ya methylation yabonye ibyemezo bya EU CE

Ku ya 8 Gicurasi 2022, Epiprobe yatangaje ko yigenga yifashishije ibikoresho bitatu byerekana kanseri ya gene methylation: TAGMe ADN Methylation Detection Kits (qPCR) ya Kanseri y'inkondo y'umura, ibikoresho bya TAGMe ADN Methylation Detection Kits (qPCR) kuri Kanseri ya Endometrale, TAGMe ADN Methylation Detection Kits (qPCR) ) kuri Kanseri ya Urothelia, yabonye ibyemezo bya EU CE kandi birashobora kugurishwa mubihugu byuburayi ndetse no mubihugu byemewe na CE.

Ibisobanuro birambuye byerekana ibintu bitatu bya ADN methylation detection ibikoresho
Ibikoresho bitatu byavuzwe haruguru birahuye neza nimashini nyamukuru ya qPCR kumasoko.Ntibasaba kuvura bisulfite, bituma inzira yo gutahura yoroshye kandi yoroshye.Ikimenyetso cya methylation imwe ikoreshwa muburyo bwa kanseri busanzwe.
Gusaba ibintu bya TAGMe ADN Methylation Detection Kits (qPCR) kuri Kanseri y'inkondo y'umura harimo:
Screen Kwipimisha kanseri y'inkondo y'umura ku bagore barengeje imyaka 30
Assessment Gusuzuma ingaruka kubagore bafite HPV
Diagn Gusuzuma ubufasha bwa kanseri y'inkondo y'umura kanseri na adenocarcinoma
Monitoring Gukurikirana nyuma yo kwibagirwa kanseri y'inkondo y'umura

Gusaba ibintu bya TAGMe ADN Methylation Detection Kits (qPCR) kuri Kanseri ya Endometrale harimo:
Gusuzuma kanseri ya endometrale mu baturage bafite ibyago byinshi
Kuziba icyuho cyo gusuzuma kanseri ya kanseri ya endometinal
Monitoring Gukurikirana nyuma yo kwibagirwa kanseri ya endometinal

Gusaba ibintu bya TAGMe ADN Methylation Detection Kits (qPCR) kuri Kanseri ya Urothelia harimo:
Gusuzuma kanseri ya urothelia mubantu bafite ibyago byinshi
St Cystoscopy yo hanze yipimisha
Gusuzuma ibyavuye mu kuvura abaganga barwaye kanseri y'uruhago
Gusuzuma chimiotherapie ku barwayi barwaye kanseri y'uruhago
Monitoring Gukurikirana nyuma yo kwibagirwa kanseri ya urothelia

Inzira ya Epiprobe'globalisation iratera imbere byihuse products kandi ibicuruzwa byatsinze Umuryango w’ubumwe bw’ibihugu by’Uburayi CE.

Kugeza ubu, Epiprobe yashyizeho itsinda ryiyandikisha ryumwuga.

Hagati aho, hamwe n’uburyo bushya bwo gukora ubushakashatsi ku bimenyetso bya kanseri ya kanseri no gusuzuma indwara, Epiprobe yakomeje guteza imbere kwagura ibicuruzwa no guhanga udushya R&D.Kuva ibikoresho bitatu byerekana kanseri ya gene methylation byabonye icyemezo cy’ubumwe bw’ibihugu by’Uburayi, byerekana ko ibyo bicuruzwa bihuye n’ubumwe bw’ibihugu by’Uburayi mu bijyanye n’amabwiriza ajyanye n’ibikoresho by’ubuvuzi bya vitro, kandi bishobora kugurishwa mu bihugu bigize Umuryango w’ubumwe bw’ibihugu by’Uburayi ndetse n’ibihugu byemera icyemezo cya EU CE.Ibi bizarushaho kunoza umurongo w’ibicuruzwa ku isi, bizamura irushanwa muri rusange, kandi bitunganyirize imiterere y’ubucuruzi ku isi.

Madamu Hua Lin, umuyobozi mukuru wa Epiprobe yavuze ko:
Imbaraga zishyizwe hamwe zo kwandikisha ibigo, R&D, imicungire y’ubuziranenge, kwamamaza no mu yandi mashami, Epiprobe yabonye icyemezo cy’ubumwe bw’ibihugu by’Uburayi cyemeza ibicuruzwa bya kanseri y'inkondo y'umura, kanseri y'amara, na kanseri ya urothelia.Kubera izo mbaraga, agace kagurishirizwamo Epiprobe kaguwe mu muryango w’ubumwe bw’ibihugu by’Uburayi no mu turere tujyanye nabyo, ibyo bikaba bitera intambwe ihamye yo gushyira mu bikorwa imiterere y’ibicuruzwa ku isi ku bicuruzwa."Epiprobe izateza imbere cyane isoko ry’isi yo gusuzuma kanseri hakiri kare, kandi iteze imbere amasoko n’imiyoboro mpuzamahanga, ishingiye ku micungire y’ubuziranenge no kwiyandikisha, uburyo bwo kuyobora laboratwari ku isi ndetse n’ikoranabuhanga rya methylation, hifashishijwe ikoranabuhanga n’ibicuruzwa bigezweho bifasha abatuye isi , bigirira akamaro ubuzima bw'isi.

Nko muri CE
CE Marking bivuga ikimenyetso cyemewe cyibicuruzwa byemewe mubihugu byuburayi.Ikimenyetso cya CE cyerekana ko ibicuruzwa bihuye n’ibisabwa by’ibanze byashyizweho n’amategeko y’ibihugu by’i Burayi bijyanye n’ubuzima, umutekano, kurengera ibidukikije no kurengera abaguzi, kandi ibyo bicuruzwa birashobora kugerwaho mu buryo bwemewe n’isoko ku isoko rimwe ry’Uburayi.

Ibyerekeye Epiprobe
Epiprobe yashinzwe mu 2018, nk'umuntu ushyigikiye kandi ukanabanza kwipimisha kanseri hakiri kare, ni uruganda rukora ikoranabuhanga ryibanda ku gusuzuma kanseri ya molekile no mu nganda z’ubuvuzi bwuzuye.Epiprobe yubakiye ku itsinda rya mbere ry’impuguke za epigenetics hamwe n’ubushakashatsi bwimbitse, Epiprobe ikora ubushakashatsi ku bijyanye no kumenya kanseri, ishimangira icyerekezo cyo "kwirinda abantu bose kanseri", yiyemeje gutahura hakiri kare, kwisuzumisha hakiri kare no kuvura kanseri hakiri kare, bizatera imbere igipimo cyo kubaho kw'abarwayi ba kanseri no kuzamura ubuzima bw'abantu bose.